Everest Management Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$622K Buy
676
+251
+59% +$254K 0.32% 41
2025
Q4
$457K Sell
425
-1
-0.2% -$956 0.25% 43
2025
Q3
$325K Sell
426
-4
-0.9% -$2.98K 0.21% 46
2025
Q2
$335K Buy
430
+4
+0.9% +$3.11K 0.24% 47
2025
Q1
$352K Buy
426
+48
+13% +$39.9K 0.32% 35
2024
Q4
$292K Buy
+378
New +$313K 0.26% 37

Other funds holding LLY

Everest Management Corp's LLY Position: Q1 2026 in Review

Everest Management Corp increased its Eli Lilly (LLY) stake by 59% in Q1 2026, buying an estimated $254K and bringing the position to 676 shares worth $622K. The position accounts for 0.32% of the portfolio, ranked #41.

Everest Management Corp first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Everest Management Corp held 676 shares of Eli Lilly worth $622K as of Q1 2026.
  • Everest Management Corp bought 251 Eli Lilly shares in Q1 2026, an estimated $254K.
  • Eli Lilly made up 0.32% of Everest Management Corp's portfolio in Q1 2026, its #41 holding.
  • Everest Management Corp first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Everest Management Corp's 13F filing for Q1 2026, filed 7 May 2026.